Pfizer Pharmaceutical Company: The World's Largest Pharmaceutical Company

Global Health Partnerships

Goal: To support innovative public health partnerships that will serve as global models in improving cancer-related health outcomes and/or supporting cancer or tobacco control efforts.

Targeted Area: Asia, Africa, Latin America, Middle East, Europe, and the US

Start Date: 2007

Pfizer's Commitment: The Pfizer Foundation, together with the Pfizer country offices will commit $33 million over the next three years (2007-2009).

Partners: Pfizer's 15 partners include: Action on Smoking and Health (ASH) International, Akebono-Kai, American Cancer Society, China Tobacco Control Association, Korean National Council of Women, European Organization for Research and Treatment of Cancer (EORTC), International Union Against Cancer (UICC), Japan Dental-Medical Association for Tobacco Council, Mexican Council on Tobacco, Philippine Business for Social Progress, QUIT UK/European Network of Quitlines, Shanghai Municipal Center for Disease Control and Prevention, The New Hope in Health Foundation, The Ralph Lauren Center for Cancer Care and Prevention and The Veronesi Foundation.

The grants will be managed by three intermediaries: the King Baudouin Foundation, Give 2 Asia, TCC Group, and The Resource Foundation with oversight from Pfizer Foundation. The Johns Hopkins University-Bloomberg School of Public Health will provide technical assistance and evaluation support.

Looking for a Pfizer Product?
A B-D E-H
I-N O-P R-Z
A-B C D-E
F-L M-P R-U V-Z